PDCD1 and neoplasm: Combining intravital real-time imaging with scRNA-seq, Garris et al. have shown that successful antitumor responses require crosstalk between a subset of tumor-infiltrating dendritic cells (DCs) in anti-PD-1 immunotherapy [29] (Figure 2B).